की कीमत क्या है CARsgen Therapeutics Holdings Limited (2171)

का मूल्य CARsgen Therapeutics Holdings Limited (2171) है $1.72

का बाजार पूंजीकरण क्या है CARsgen Therapeutics Holdings Limited (2171)

का बाजार पूंजीकरण CARsgen Therapeutics Holdings Limited (2171) है $981.92M

CARsgen Therapeutics Holdings Limited (2171) लाभांश

CARsgen Therapeutics Holdings Limited, a biopharmaceutical firm founded in Shanghai, China, in 2014, focuses on the discovery, development, and commercialization of advanced chimeric antigen receptor T (CAR-T) cell therapies. The company's efforts are directed toward treating various hematological malignancies and solid tumors across China and the United States. Its robust pipeline includes several key candidates: CT053, an autologous CAR-T product, is currently in a pivotal Phase II trial in China for relapsed/refractory multiple myeloma. Additionally, CT041, another autologous CAR-T, is undergoing Phase Ib/II clinical trials for advanced gastric/gastroesophageal junction and pancreatic cancers in China, and Phase Ib trials for comparable indications in the U.S. CARsgen is also advancing CT011, an autologous CAR-T candidate, through Phase I for patients with Glypican-3 positive advanced hepatocellular carcinoma, and CT032, an autologous CAR-T, in Phase I/II for B cell Non-Hodgkin's lymphoma in China. Furthermore, its pipeline features AB011, a humanized monoclonal antibody in Phase I for CLDN18.2 positive solid tumors in China, as well as CT017, an autologous Glypican-3-targeted CAR-T for hepatocellular carcinoma, and other promising therapies for solid tumors.

वर्ष	लाभांश (स्टॉक स्प्लिट समायोजित)	परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष

लाभांश (स्टॉक स्प्लिट समायोजित)

परिवर्तन

प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष	लाभांश	परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष

लाभांश

परिवर्तन

प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

कंपनी	लाभांश भुगतान की संख्या	देश
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
CSL Limited CSL.AX	64.00%	AU
Moderna, Inc. MRNA.US	0.00%	US
Lonza Group AG LONN.SW	0.00%	CH

कंपनी

लाभांश भुगतान की संख्या

देश